Search Results - "Wenk, G. L."

Refine Results
  1. 1

    Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine by Rosi, S., Ramirez-Amaya, V., Vazdarjanova, A., Esparza, E. E., Larkin, P. B., Fike, J. R., Wenk, G. L., Barnes, C. A.

    Published in Brain (London, England : 1878) (01-09-2009)
    “…Understanding how the hippocampus processes episodic memory information during neuropathological conditions is important for treatment and prevention…”
    Get full text
    Journal Article
  2. 2

    Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat by Rosi, S., Vazdarjanova, A., Ramirez-Amaya, V., Worley, P.F., Barnes, C. A., Wenk, G.L.

    Published in Neuroscience (03-11-2006)
    “…Neuroinflammation is reliably associated with the pathogenesis of a number of neurodegenerative diseases, and can be detected by the presence of activated…”
    Get full text
    Journal Article
  3. 3

    Differential rescue of spatial memory deficits in aged rats by L-type voltage-dependent calcium channel and ryanodine receptor antagonism by Hopp, S.C, D’Angelo, H.M, Royer, S.E, Kaercher, R.M, Adzovic, L, Wenk, G.L

    Published in Neuroscience (07-11-2014)
    “…Highlights • Ryanodine receptor expression is negatively correlated with memory in aged rats. • Antagonism of ryanodine receptors improves spatial memory…”
    Get full text
    Journal Article
  4. 4

    Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation by Marchalant, Y, Rosi, S, Wenk, G.L

    Published in Neuroscience (23-02-2007)
    “…Abstract Cannabinoid receptors (CBr) stimulation induces numerous central and peripheral effects. A growing interest in the beneficial properties of…”
    Get full text
    Journal Article
  5. 5

    Chronic Brain Inflammation Results in Cell Loss in the Entorhinal Cortex and Impaired LTP in Perforant Path-Granule Cell Synapses by Hauss-Wegrzyniak, B., Lynch, M.A., Vraniak, P.D., Wenk, G.L.

    Published in Experimental neurology (01-08-2002)
    “…Alzheimer's disease (AD) is characterized by chronic neuroinflammation, significant temporal lobe cell loss, and dementia. We investigated the influence of…”
    Get full text
    Journal Article
  6. 6

    Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors by Barnes, C.A, Meltzer, J, Houston, F, Orr, G, McGann, K, Wenk, G.L

    Published in Neuroscience (01-01-2000)
    “…The function of the cholinergic system is known to change during normal aging and in pathological conditions such as Alzheimer’s disease. The present study was…”
    Get full text
    Journal Article
  7. 7

    Chemokine receptor 5 antagonist d-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease by Rosi, S., Pert, C.B., Ruff, M.R., McGann-Gramling, K., Wenk, G.L.

    Published in Neuroscience (2005)
    “…Chronic neuroinflammation plays a prominent role in the progression of Alzheimer's disease. Reactive microglia and astrocytes are observed within the…”
    Get full text
    Journal Article
  8. 8

    The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition by WILLARD, L. B, HAUSS-WEGRZYNIAK, B, DANYSZ, W, WENK, G. L

    Published in Experimental brain research (01-09-2000)
    “…The proinflammagen lipopolysaccharide (LPS) was infused chronically (37 days) into the basal forebrain of rats. The current study determined whether the…”
    Get full text
    Journal Article
  9. 9

    The Nucleus Basalis Magnocellularis Cholinergic System: One Hundred Years of Progress by Wenk, Gary L.

    Published in Neurobiology of learning and memory (01-03-1997)
    “…The nucleus basalis magnocellularis (NBM) contains a population of large cholinergic (Ch) neurons that send their axons to the entire cortical mantle, the…”
    Get full text
    Journal Article
  10. 10

    Cholinergic Activity in Autism: Abnormalities in the Cerebral Cortex and Basal Forebrain by Perry, Elaine K., Lee, Mandy L.W., Martin-Ruiz, Carmen M., Court, Jennifer A., Volsen, Stephen G., Merrit, Jenny, Folly, Elizabeth, Iversen, Portia E., Bauman, Margaret L., Perry, Robert H., Wenk, Gary L.

    Published in The American journal of psychiatry (01-07-2001)
    “…OBJECTIVE: Measures of cholinergic transmitter activity were investigated in patients with autism because of reported neuropathological abnormalities in…”
    Get full text
    Journal Article
  11. 11

    The toxicity of tumor necrosis factor-α upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for alzheimer's disease by Wenk, G.L, McGann, K, Hauss-Wegrzyniak, B, Rosi, S

    Published in Neuroscience (01-01-2003)
    “…Inflammation and reduced forebrain norepinephrine are features of Alzheimer's disease that may interact to contribute to the degeneration of specific neural…”
    Get full text
    Journal Article
  12. 12

    Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats by Willard, B, Hauss-Wegrzyniak, B, Wenk, G.L

    Published in Neuroscience (1999)
    “…Inflammatory processes may play a critical role in the degeneration of basal forebrain cholinergic cells that underlies some of the cognitive impairments…”
    Get full text
    Journal Article
  13. 13

    Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease by Hauss-Wegrzyniak, Beatrice, Dobrzanski, Pawel, Stoehr, James D, Wenk, Gary L

    Published in Brain research (12-01-1998)
    “…Inflammatory processes may play a critical role in the pathogenesis of the degenerative changes and cognitive impairments associated with Alzheimer's disease…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats by Hauss-Wegrzyniak, Beatrice, Vannucchi, Maria G., Wenk, Gary L.

    Published in Brain research (17-03-2000)
    “…We investigated the ultrastructural, immunohistochemical, biochemical and behavioral effects of chronic neuroinflammation in young rats produced by injection…”
    Get full text
    Journal Article
  16. 16

    LPS-induced neuroinflammatory effects do not recover with time by Hauss-Wegrzyniak, Beatrice, Vraniak, Peter D, Wenk, Gary L

    Published in Neuroreport (05-06-2000)
    “…Inflammatory processes develop in the vicinity of the neuro-pathological hallmarks associated with Alzheimerʼs disease (AD) and may play a role in the…”
    Get full text
    Journal Article
  17. 17

    Long-Term Estrogen Therapy Worsens the Behavioral and Neuropathological Consequences of Chronic Brain Inflammation by Marriott, L. K, Hauss-Wegrzyniak, B, Benton, R. S, Vraniak, P. D, Wenk, G. L

    Published in Behavioral neuroscience (01-10-2002)
    “…Alzheimer's disease (AD) is accompanied by chronic neuroinflammation and occurs with greater incidence in postmenopausal women. The increased incidence may be…”
    Get full text
    Journal Article
  18. 18

    Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors by Woodruff-Pak, D.S, Vogel, R.W, Wenk, G.L

    Published in Neuroscience (01-01-2003)
    “…Patch-clamp recordings of single ion channel activity demonstrated that donepezil, but not galantamine, could be blocked by the nicotinic cholinergic…”
    Get full text
    Journal Article
  19. 19

    Neuropathologic changes in Alzheimer's disease: potential targets for treatment by Wenk, Gary L

    Published in The journal of clinical psychiatry (01-01-2006)
    “…The cognitive symptoms of Alzheimer's disease (AD) are believed to be caused not only by the loss of neurons in the cholinergic and glutamatergic neural…”
    Get full text
    Journal Article
  20. 20

    Rapamycin inhibits mTOR/p70S6K activation in CA3 region of the hippocampus of the rat and impairs long term memory by Lana, D., Di Russo, J., Mello, T., Wenk, G.L., Giovannini, M.G.

    Published in Neurobiology of learning and memory (01-01-2017)
    “…•mTOR/p70S6K activation in area CA3 are involved in long term memory formation.•Rapamycin inhibited mTOR/p70S6K activation at 4h and impaired long term memory…”
    Get full text
    Journal Article